- Viestejä: 10605
- Vastaanotettu kiitos 165
Yli puolet sai koronasta vaurioita aivoihin
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Prior reports from the SARS CoV-1 epidemic identified a range of psychiatric complications in affected patients with SARS, including adjustment-related anxiety, depression, suicidal ideation, as well as organic hallucinosis and organic manic disorder.3 High-dose corticosteroid use has been identified as a significant associated factor in psychotic presentations.3, 4, 5 Long-term survivors of SARS-CoV-1 were found to have post traumatic stress disorder (54%), depression (39%), panic disorder (32.5%), and obsessive compulsive disorder (15.6%) 31–50 months after the diagnosis; however, short- or long-term psychosis was not found in this cohort.6
Researchers at Orygen and La Trobe University in Melbourne, Australia have completed a rapid review of contemporary epidemic and pandemic research to assess the potential impact of COVID-19 on people with psychosis.
The review, published online ahead of print in Schizophrenia Research, found an increase in the prevalence of psychosis as a result of COVID-19 would likely be associated with viral exposure, pre-existing vulnerability and psychosocial stress. The review also suggested that people with psychosis may present a major challenge and potential infection control risk to clinical teams working with them.
Cases of cannabis-induced psychosis increase during COVID-19 pandemic
Dozens of patients across Scotland have been treated for psychosis in recent weeks, as evidence mounts that the coronavirus pandemic can trigger mental illness.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Study Suggests COVID-19 May Cause Surge In Psychosis Diagnoses & Severity
First-episode psychosis reported in patient self-medicating with chloroquine for COVID-19
COVID-19: reminder of the risks of chloroquine and hydroxychloroquine
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
World's dominant strain of coronavirus 'is 10 TIMES more infectious than the one that jumped to humans in China' because it mutated so its vital spike protein doesn't snap as often in the body, scientists say
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kahluualtaalla toistuvasti vieraillut koronaviruksen kantaja altisti ihmisiä pitkin viime viikkoa tartunnalle Espoossa – ”Käytännössä mahdotonta etsiä siellä olleita ihmisiä”
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
As coronavirus spreads to people under 40, it's making them sicker — and for longer — than once thought
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
But a study published earlier this month found the number of Swedes who have formed antibodies to the virus is smaller than expected, dashing hopes that herd immunity could be achieved.
The study, carried out by the country’s Public Health Agency, found that just 6.1 per cent of the country’s population had developed coronavirus antibodies by late May. This figure falls far short of Dr Tegnell’s prediction.
Experts have said achieving herd immunity would require at least 60 per cent of the population to become immune to the virus.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Coronavirus is killing the Dutch mink industry
The Netherlands, a top exporter of mink, has killed more than 500,000 of the animals this month to stop the spread of disease.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.
Kirjaudu tai Rekisteröidy liittyäksesi keskusteluun.